Investor Presentaiton

31st January 2024 So also Total Sales continues to grow 13% 5% 179% 13% Q3 Consolidated Branded Generics (Rs. Cr.) USA Generics (Rs. Cr.) Africa Institution (Rs. Cr.) Consolidated Sales (Rs. Cr.) 1,09 3 755 266 252 86 964 666 31 Q3 FY23 Q3 FY24 Q3 FY23Q3 FY24 Q3 FY23 Q3 FY24 69% 23% 8% of Total Revenue of Total Revenue of Total Revenue Q3 FY23 Q3 FY24 27 ajanta

View entire presentation